Publications:

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors.

Scientific Reports

Wei, Yuming Y; Poon, Daniel C DC; Fei, Rong R; Lam, Amy S M AS; Au-Yeung, Steve C F SC; To, Kenneth K W KK

Publication Date: 2016-05-06

Variant appearance in text: EGFR: D800L

PubMed Link: 27150583

Variant Present in the following documents:

• Main text
• srep25363-s1.pdf
• srep25363.pdf

View BVdb publication page